Klaria Pharma Holding AB (publ) issues notice to attend an extraordinary general meeting
The shareholders in Klaria Pharma Holding AB (publ), reg. no. 556959-2917, are hereby given notice to attend the extraordinary general meeting at 2 November 2020 at 10.00 a.m. (CET) at the premises of Setterwalls Advokatbyrå at Sturegatan 10, 114 36 Stockholm, Sweden. Registration for the meeting commences at 09.30 a.m. (CET).Notice Shareholders wishing to participate at the meeting must: i. be entered in the shareholders’ register, kept by Euroclear Sweden AB (the Swedish Central Securities Depository & Clearing Organisation), on the record day which is 23 October 2020; andii.